Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It offers products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include dietary supplements, skin care cosmetics, sun protection creams, tools, serum, masks, carboxytheraphy, and intra-articular injections for regeneration of the knee joints. It also provides reconstructive products, such as hip endoprostheses, 3D endoportesis, and synthetic tendon ligaments; AdipSculpt, a fat graft collection and preparation kit for controlling vacuum during liposuction; HA, kits for collecting and preparing adipose tissue for autologous transplantation; and Endor, is a dermocosmetics based on a patented gold molecule combined with short chains of HA with properties that strongly induce the production of endogenous collagen, elastin and hyaluronic acid. The company offers its products to public and private hospitals. Massmedica S.A. was founded in 2011 and is headquartered in Warsaw, Poland.
Metrics to compare | MSMP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMSMPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.4x | 20.1x | −0.5x | |
PEG Ratio | −1.00 | −0.06 | 0.00 | |
Price/Book | 2.6x | 1.7x | 2.6x | |
Price / LTM Sales | 0.5x | 0.7x | 3.3x | |
Upside (Analyst Target) | - | 28.2% | 45.5% | |
Fair Value Upside | Unlock | 10.4% | 5.1% | Unlock |